MetLife (MET) Q4 2025 earnings review
Core Earnings Accelerate While Derivatives Drag GAAP Results
MetLife closed 2025 with strong operating momentum, delivering a 13% YoY increase in Adjusted Earnings to $1.65 billion, driven by robust volume growth in Retirement & Income Solutions (RIS) and improved underwriting margins in Group Benefits. However, reported Net Income fell 37% to $778 million, heavily impacted by $646 million in net derivative losses tied to higher interest rates and equity markets. The company executed significantly on its 'New Frontier' strategy, closing the PineBridge acquisition and securing record Pension Risk Transfer (PRT) deals, which spiked quarterly revenues by 29%.
🐂 Bull Case
The direct expense ratio improved significantly to 11.6% from 13.1% a year ago, beating the company's own targets. Management attributes this to the 'New Frontier' efficiency initiatives.
RIS Adjusted PFOs nearly doubled (+99%) to $7.2 billion, driven by record Pension Risk Transfer sales. Adjusted earnings for the segment grew 18%, benefiting from both volume and favorable variable investment income.
MetLife returned nearly $4.4 billion to shareholders in FY25. With $3.6 billion in holding company cash (within target range) and improving operating cash flows, the capital return story remains intact.
🐻 Bear Case
Net Income continues to be noisy, dropping 37% due to derivative and investment losses. While 'Adjusted' metrics look good, the $646 million pre-tax derivative loss signals ongoing sensitivity to rate and currency volatility.
LatAm, usually a growth engine, saw adjusted earnings fall 1% reported (-9% constant currency) due to a $29 million notable tax adjustment in Mexico. While PFOs grew, the earnings drag highlights regional regulatory risks.
⚖️ Verdict: 🟢
Bullish. The divergence between falling Net Income and rising Adjusted Earnings is noise; the signal is in the double-digit growth of core operating profit and the massive volume wins in RIS. Expense control is excellent.
Key Themes
Pension Risk Transfer (PRT) Boom
The Retirement and Income Solutions (RIS) segment delivered a massive revenue beat, with Adjusted PFOs exploding 99% YoY to $7.2 billion. This was driven by record PRT sales and $11.1 billion in U.K. longevity reinsurance transactions. This proves the 'New Frontier' strategy of capitalizing on the corporate de-risking trend is executing at scale.
Group Benefits Margins Recovering
After a dip in mid-2025 (Q2 earnings fell 25% YoY), Group Benefits has stabilized. Q4 Adjusted Earnings rose 12% YoY to $465 million. Management cited 'favorable life underwriting' as the primary driver, suggesting mortality headwinds have subsided.
Investment Portfolio Noise
While Net Investment Income rose 10% to $5.9 billion, the portfolio faced headwinds. Net investment losses were $160 million, and Net Derivative losses were $646 million (driven by higher long-term rates and stronger equity markets). Although Variable Investment Income (VII) improved to $497 million (driven by Private Equity), the GAAP volatility remains a complex factor for investors to model.
MetLife Investment Management (MIM) Expansion
MIM is undergoing a step-change in scale. The acquisition of PineBridge Investments closed on December 30, 2025, contributing to a 27% surge in Total AUM to $741.7 billion. Adjusted earnings for the MIM segment skyrocketed 275% to $60 million in Q4, signaling a new era of fee-based earnings power.
Latin America Regulatory Headwind
Latin America, typically a star performer, saw Adjusted Earnings contract 1% reported (-9% constant currency). This was specifically driven by a $29 million notable item related to tax adjustments in Mexico. While sales growth remains strong (+25% PFOs), regulatory and tax volatility in the region is a drag on bottom-line translation.
Operational Efficiency
MetLife continues to lean out its cost structure. The direct expense ratio (ex-notables/PRT) fell to 11.6% in Q4 from 13.1% a year prior. For the full year, the ratio was 11.7%, beating the company's targets. This operating leverage is critical for maintaining ROE targets of 15-17%.
Other KPIs
Accelerating. Up 14% YoY from $34.28. This reflects the retention of earnings and equity market strength, despite the drag from higher rates on the fixed income portfolio valuation.
Accelerating. Improved significantly from 15.4% in 24Q4. This is well within the 'New Frontier' target range of 15-17%, demonstrating strong capital efficiency.
Accelerating. EMEA delivered a standout performance with earnings jumping to $97 million. Sales grew 24% on a constant currency basis, showing broad-based strength across the region.
Guidance
Stable. CEO Michel Khalaf reaffirmed confidence in the 'New Frontier' commitments. While specific FY26 numerical guidance ranges were referenced as being in the 8-K (not provided), the strategic targets remain: 15-17% Adjusted ROE and double-digit Adjusted EPS growth over the plan period.
Key Questions
PineBridge Integration Risks
With the PineBridge acquisition closing at year-end, what is the expected integration cost profile for 2026, and how quickly will the synergy benefits accrete to MIM's margin?
Variable Investment Income Visibility
VII rebounded to $497 million in Q4 driven by private equity. Given the volatility seen in Q2 ($195M) and Q3 ($483M), do you have improved visibility for 2026 PE returns, or should we model conservatively?
LatAm Tax Impact Persistence
Is the $29 million tax adjustment in Mexico a one-time reset, or does it signal a structural change in the effective tax rate for the Latin America segment going forward?
Capital Return Pace
With $3.6 billion in holding company cash and strong PRT flows, will the pace of buybacks in 2026 accelerate versus the ~$4.4 billion returned in 2025?